Return
IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma
M
S
E
P
P
E
N
A
D
E
A
B
F
J
K
P
DOI:10.1016/j.mtbio.2026.103539.png)
Abstract
En 中文
• Biodegradable FTH1 nanocages enable dual-drug glioma therapy. • 68 Ga-labeled FTH1 nanocages integrate PET imaging and therapy. • Dual-drug nanotherapy suppresses glioma growth in ovo. • Kinomics profiling reveals IDH-dependent kinase signaling adaptation.
Keywords:
Protein nanocarrier
Blood-brain barrier
Glioblastoma
Chemotherapeutic payload
PET
Imaging
Kinase signaling
Journal
IF:
10.2
Papers:
3.6K
Citations:
9.5K
